With advancements in technology, researchers say people with diabetes can easily access health data and plan for the ...

Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

On Friday, DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $75.88 which represents a slight increase of $1.20 or 1.61% from the prior close of $74.68. The stock opened at $75.51 and ...

This week Bobbi Conner talks with MUSC's Dr. Aundrea Loftley about using a continuous glucose monitor for diabetes management ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

24 analysts are following DexCom and have set target prices ranging from $75.0 to $120.0 per share. On average, they have ...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...

Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

David Padilla, 77, a Westbury resident, has been living with type 2 diabetes for over 40 years and continues to live life to ...